Subscribe free

Metabolic and Bariatric Surgery ·

Roux-en-Y Gastric Bypass Outperforms Sleeve Gastrectomy in Long-Term Outcomes

After a decade of follow-up in the SM-BOSS trial, Roux-en-Y gastric bypass (RYGB) demonstrated superior efficacy in achieving percentage excess body mass index loss compared to sleeve gastrectomy (SG), with means of 65.9% and 56.1% respectively. Though total weight loss showed no significant difference, patients undergoing SG faced higher conversion rates due to inadequate weight loss and increased gastroesophageal reflux incidences. These findings highlight the long-term advantages of RYGB for severe obesity treatment.

Journal Article by Kraljevic M, Süsstrunk J (…) Peterli R et 7 al. in JAMA Surg

read the whole article in JAMA Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →